An hemolysis-in-gel test for bovine brucellosis.

Area of Science:

• Veterinary Immunology
• Bacteriology
• Diagnostic Assays

Background:

• Brucellosis remains a significant concern in cattle populations worldwide.
• Accurate and sensitive diagnostic tests are crucial for effective control and eradication programs.
• Existing diagnostic methods for bovine brucellosis have limitations in sensitivity or early detection.

Purpose of the Study:

• To develop and evaluate a novel hemolysis-in-gel test (HIGT) for detecting bovine antibodies against Brucella abortus.
• To compare the performance of HIGT with established diagnostic tests, including CFT, BPAT, STAT, and SPAT.
• To assess the utility of HIGT in detecting infection in naturally infected cattle and vaccinated animals.

Main Methods:

• Development of HIGT utilizing guinea pig complement and B. abortus-coated erythrocytes in agarose gel.
• Comparison of HIGT results with CFT, BPAT, STAT, and SPAT using sera from brucellosis-free, infected, and vaccinated cattle.
• Evaluation of test sensitivity, specificity, and timing of antibody detection in different infection scenarios.

Main Results:

• HIGT demonstrated high specificity with a false-positive rate of 0.29% in brucellosis-free cattle.
• HIGT showed greater sensitivity and earlier detection for Brucella abortus biotype 1 infections compared to other tests.
• HIGT exhibited lower sensitivity for biotype 4 infections and delayed, prolonged reactions in vaccinated animals.

Conclusions:

• The hemolysis-in-gel test (HIGT) is a potentially valuable tool for diagnosing bovine brucellosis, particularly for early detection of certain Brucella abortus biotypes.
• Further standardization of HIGT protocols and antigen optimization are necessary to enhance sensitivity for all Brucella abortus biotypes, especially biotype 4.
• The test's performance in vaccinated animals requires additional investigation to differentiate between vaccination response and active infection.